Company Filing History:
3 out of 7 
2 out of 55 
2 out of 950 
Years Active: 2016-2021
Title: The Innovative Contributions of Satoko Hamamura
Introduction
Satoko Hamamura, based in Higashihiroshima, Japan, is an accomplished inventor known for his significant contributions to the field of biotechnology. With three patents to his name, he has made strides in innovative research, particularly pertaining to transgenic models useful for studying liver disease.
Latest Patents
One of Hamamura's latest patents is titled "Urokinase-type plasminogen activator transgenic mouse." This invention provides a unique mouse model that exhibits high liver damage while possessing the urokinase-type plasminogen activator (uPA) gene in a heterozygous form. The detailed method for efficiently preparing this mouse encompasses several steps: transforming mouse embryonic stem cells with a liver-specific promoter and cDNA encoding the urokinase-type plasminogen activator, injecting these cells into host embryos, and ultimately crossing chimeric mice to achieve a stable transgenic model. This innovative approach has potential applications for studying liver diseases and developing therapeutic interventions.
Career Highlights
Throughout his career, Hamamura has worked with prominent companies such as Phoenixbio Co., Ltd. and the Tokyo Metropolitan Institute of Medical Science. These institutions have provided a platform for his research, allowing him to advance his work in genetic engineering and transgenic models.
Collaborations
Collaborating with other notable researchers, Hamamura has teamed up with colleagues like Chise Mukaidani and Michinori Kohara. Their combined expertise has broadened the scope and impact of Hamamura's inventions, fostering a collaborative spirit that drives innovation in the biomedical field.
Conclusion
Satoko Hamamura's contributions to the development of innovative biotechnological solutions underscore the importance of diligent research and collaboration in advancing medical science. His work on transgenic mouse models serves as a testament to the power of innovation in understanding complex diseases, paving the way for future advancements in the field.